Join Dr Karelle Benistan, leading expert from the French reference centre for non-vascular EDS, as she guides you through the diagnosis and management of EDS from a haematology perspective. Gain…
Cedric Hermans sits down with Jan Blatný, Consultant Haematologist at Masaryk University and University Hospital Brno, EHCC and EuroBloodNet Centre, and former EAHAD President (2024–2026), to explore the evolving role…
The recent withdrawal of Roctavian from the market has raised important questions for clinicians, patients, and healthcare systems involved in the management of haemophilia A gene therapy. As the first…
The WFH 2026 World Congress will include over 80 hours of continuing educational sessions across the Medical and People with Bleeding Disorders (PWBD) tracks, as well as six professional development…
The European Hematology Association (EHA) community consists of doctors (haematologists), researchers (PhD or otherwise), patients (and advocacy groups), geneticists, nurses, and more mainly across Europe, including non-EU member states.
Gene therapy is transforming the treatment landscape of hemophilia, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar, leading experts will discuss…
ISTH is a worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of conditions related to thrombosis and haemostasis.
